Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for neurogenic detrusor overactivity-related urinary incontinence in children
2014-004641-27Phase 3Terminated
- Sponsor
- UZ Leuven
- Start
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A in detrusor hyperreflexia (DH) and neurogenic bladder, sponsored by UZ Leuven. Primary endpoint: Efficacy based on micturition diaries. Started Apr 2015; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
detrusor hyperreflexia (DH)neurogenic bladder
Beyond the preview
Go deeper on 2014-004641-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004641-27.